Stocktoria
RenovoRx, Inc. RNXT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-08-17
RenovoRx, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| VOLL MARK | Chief Financial Officer | 2026-05-19 | Buy | 25,000 | $0.79 |
| VOLL MARK | Chief Financial Officer | 2026-04-03 | Grant | 80,000 | — |
| VOLL MARK | Chief Financial Officer | 2026-03-25 | Grant | 12,380 | — |
| VOLL MARK | Chief Financial Officer | 2026-03-20 | Buy | 97,200 | — |
| Marton Laurence | director | 2026-03-20 | Buy | 9,720 | — |
| Bagai Shaun | Chief Executive Officer | 2026-03-20 | Buy | 24,300 | — |
| RYAN UNA S | director | 2022-04-22 | J | 16,206 | $1.62 |
| RYAN UNA S | director | 2022-04-22 | J | 26,838 | $0.93 |
Source: SEC EDGAR filings · CIK 0001574094 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.